These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9579302)

  • 21. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of agitation in bipolar disorder across the life cycle.
    Alderfer BS; Allen MH
    J Clin Psychiatry; 2003; 64 Suppl 4():3-9. PubMed ID: 12672259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression predicts the pattern of cognitive impairment in early Parkinson's disease.
    Stefanova E; Potrebic A; Ziropadja L; Maric J; Ribaric I; Kostic VS
    J Neurol Sci; 2006 Oct; 248(1-2):131-7. PubMed ID: 16780884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
    Fleischhaker C; Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid Clozapine Titration in an Acutely Agitated Patient With Schizoaffective Disorder: A Case Report.
    Hammond JC; Lahti AC; Kraguljac NV
    J Clin Psychopharmacol; 2016 Jun; 36(3):276-7. PubMed ID: 26981924
    [No Abstract]   [Full Text] [Related]  

  • 29. Strategies for diagnosing and treating agitation in the aging.
    Barnes R; Raskind M
    Geriatrics; 1980 Mar; 35(3):111-9. PubMed ID: 6101569
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson's disease.
    Hardwick A; Ward H; Hassan A; Romrell J; Okun MS
    Neurocase; 2013; 19(6):587-91. PubMed ID: 22934916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of disturbed behavior in patients with dementia].
    van de Boogerd ME; Pisters-van Roy AA; Wiertz YD
    Ned Tijdschr Geneeskd; 1992 Jul; 136(29):1419-20. PubMed ID: 1353612
    [No Abstract]   [Full Text] [Related]  

  • 32. [Depression and anxiety: from clinic to pharmacological treatment].
    Wikinski S
    Vertex; 2004; 15(57):208-12. PubMed ID: 15505682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A trial of dextroamphetamine in patients with involutional agitated depression.
    Ward NG; Lampe TH
    J Clin Psychiatry; 1982 Jan; 43(1):35-6. PubMed ID: 7054155
    [No Abstract]   [Full Text] [Related]  

  • 34. Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea.
    Sajatovic M; Verbanac P; Ramirez LF; Meltzer HY
    Neurology; 1991 Jan; 41(1):156. PubMed ID: 1670739
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic management of behavioral problems in adult dental patients with severe cognitive impairment.
    Volicer L
    Gerodontics; 1988 Aug; 4(4):160-1. PubMed ID: 2908331
    [No Abstract]   [Full Text] [Related]  

  • 36. [Case report about central effects of physostigmine (author's transl)].
    Eckstein KL; Vincente-Eckstein A
    Anaesthesist; 1980 Jul; 29(7):376-8. PubMed ID: 7425264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine in hemiballismus: report of two cases.
    Stojanovic M; Sternic N; Kostic VS
    Clin Neuropharmacol; 1997 Apr; 20(2):171-4. PubMed ID: 9099471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of sundowning. A selective review of pharmacological and nonpharmacological studies.
    McGaffigan S; Bliwise DL
    Drugs Aging; 1997 Jan; 10(1):10-7. PubMed ID: 9111704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How best to manage treatment-resistant depression?
    Hicks P; Hicks XP; Meyer H; Shisslak C
    J Fam Pract; 2010 Sep; 59(9):490-7. PubMed ID: 20824225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The aim of neuroleptics in the context of the treatment of depression].
    Guensberger E; Molcan J
    Agressologie; 1978; 19(C):121-4. PubMed ID: 35991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.